Selling And Administration Expenses 更改
AstraZeneca USD 3.59B 1.96B 2025-03
Galapagos EUR 43.8M 2.55M 2025-03
Genmab DKK 126M 1.12B 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
GRIFOLS EUR 324.65M 55.17M 2025-03
Hikma Pharmaceutical USD 288M 8M 2024-12
Qiagen NV USD 137.94M 3.77M 2025-03
UCB EUR 1.29B 221M 2024-12



argenx SE 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2025.